Portuguese Registry on Interventional Cardiology (PRIC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01867801|
Recruitment Status : Unknown
Verified June 2017 by Portuguese Society of Cardiology.
Recruitment status was: Recruiting
First Posted : June 4, 2013
Last Update Posted : June 9, 2017
|Condition or disease|
|Coronary Artery Disease|
Cardiovascular disease remains the main cause of death in Portugal and approximately one quarter of these are directly to ischemic heart disease. In order to better characterize percutaneous coronary intervention in Portugal, the Portuguese Society of Cardiology has promoted the Portuguese registry on percutaneous coronary intervention.
This will include all adult patients (≥ 18 years), eligible for percutaneous coronary intervention (PCI) in accordance with PCI state-of-art recommendations (including unstable and stable coronary disease). The Cardiology department where the patient has been hospitalized is responsible for the patient inclusion in the study.
Excluded patients are those in whom the preferred treatment is Coronary Artery Bypass Graft (CABG), age under 18 years or life expectancy of less than 12 months.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||50000 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||Portuguese Registry on Interventional Cardiology|
|Study Start Date :||January 2002|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||December 2018|
- Major adverse cardiac event rate (MACE) MACE: A composite of all cause death, documented Myocardial Infarction (MI), unplanned hospitalization leading to urgent revascularization. [ Time Frame: 24 months ]
- Total mortality [ Time Frame: 12 month ]Total mortality at 12 month
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01867801
|Contact: Sandra M Corker||00351 239 838 firstname.lastname@example.org|
|Coimbra, Portugal, 3000-306|
|Contact: Sandra M Corker 00351 239 838 101 email@example.com|
|Principal Investigator:||Marco Costa, MD||Portuguese Society of Cardiology|